Society for Pediatric Pain Medicine
Better Care for Children in Pain

The Society for Pediatric Pain Medicine (SPPM) aims to advance the quality of anesthesia care and the alleviation of pain-related conditions in children.

Society for Pediatric
Pain Medicine

Better Care for Children in Pain

Member Menu

  • Member Login
  • Forgot Password?
Generic selectors
Exact matches only
Search in title
Search in content
  • Home
  • About
    • Vision Statement
    • Board of Directors
    • Committees
    • SPPM Bylaws
    • FAQs
    • Contact
  • Meetings
    • Upcoming Meetings
    • Past Meetings
    • Other Meetings
    • Exhibitor Information
  • Education
    • Questions of the Month
    • Case Reports
    • Books for Clinicians
  • Membership
    • Member Benefits
    • Membership Classifications
    • Renew Your Dues
    • Join Now
  • Resources
    • Latest News
    • Newsletters
    • COVID-19 Resources
    • Publications
    • Employment
      • Pediatric Pain Fellowships
    • Links of Interest
  • Patients & Families
    • Useful Links
    • Books for Patients and Families
    • Mobile Apps
    • FAQs
  • Trainees
    • Pediatric Chronic Pain Fellowship Programs
    • Pediatric Acute Pain/Regional Anesthesia Fellowship Programs

Question of the Month – December 2020

Welcome to your Question of the Month - December 2020

December's question is written by:  




Ashlee Holman, MD
Assistant Professor of Anesthesiology
University of Michigan Health System




A 16-year old male with sickle cell disease presents to the hospital in acute pain crisis. His sickle cell disease has worsened over the last few years, and optimal pain control during acute crises has been difficult to achieve. His analgesic regimen is complex and includes non-pharmacological methods (e.g. distraction techniques, behavioral modification therapy) as well as acetaminophen, NSAIDs, hydromorphone, methadone, and most recently, initiation of a lidocaine infusion. He reports low pain scores on the intravenous lidocaine and wonders if he can continue lidocaine in some form as an outpatient. The patient’s care team suggests transition to oral mexiletine as a replacement for intravenous lidocaine. Which of the following is false?

clock.png

Time is Up!

Upcoming Meeting Information


SPPM 8th Annual Meeting
April 24-25, 2021
VIRTUAL CONFERENCE

Mobile Meeting Guide

Registration

 

Join SPPM
Renew
Donate
Get Involved
Upcoming
Job Postings
Return to top of page
2209 Dickens Road, Richmond, VA 23230 • 804-282-9780 • sppm@societyhq.com
Copyright © 2021 Society for Pediatric Pain Medicine | View Privacy Policy